IPI-443

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameIPI-443
Drug Alias NameIPI-443
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase delta inhibitorsPhosphatidylinositol 3 kinase gamma inhibitors
TargetsPhosphatidylinositol-4,5-Bisphosphate 3 kinase gammaPhosphatidylinositol 3 kinase delta
Therapy Area/IndicationsInflammationHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInfinity Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInfinity Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsInflammationHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A